Moreover, the restoration of EZH2 expression in cells stably expressing miR-217 (SGC7901/miR-217) was able to counteract the inhibitory effects of miR-217 in the gastric cancer cells (Figure 6A-6D). The gene discussed is EZH2; the disease is gastric cancer.